Kropz

KRPZ · AIM · Basic Resources · mcap £7.0m · 0.4p 4 open situations →

EV: −£644k
EV / EBIT: –
Net cash: £2.6m
FCF yield: –
Revenue: –
Share price 1y: −17%
Insiders 12m: no deals
Next report: around 17 Dec

Beta Briefing, track record and signals & risks are not ready for Kropz yet.

We follow 960 UK small caps and every one of their announcements – often hundreds per company. 101 companies are already wired into a briefing: browse them.

Timeline · every situation

dots = announcements

2026 AIM suspension over late accounts Elandsfontein trial production ramp-up Subscription and WRAP retail offer WWF-SA environmental offset lawsuit Profit warning

Open · 4

Legal & regulatory

AIM suspension over late accounts

Suspension from 1 October 2026

Follows from Elandsfontein trial production ramp-up – Phosrock production halted; restructuring begun

On 30 September 2026 Kropz said it cannot publish its FY26 annual accounts by the AIM Rule 19 deadline of 30 September 2026. The audit is ongoing and well progressed. Shares are suspended from 7.30 a.m. on 1 October 2026 until the accounts are published. This follows the 7 September restructuring and halt to Phosrock production.

Suspension: From 7.30 a.m. on 1 October 2026 30 Sep 2026 ↗
Audit status: Ongoing and well progressed 30 Sep 2026 ↗
Next milestone: Publication of FY26 Annual Accounts; no date stated 30 Sep 2026 ↗

Next: Publish FY26 Annual Accounts to end suspension

30 Sep 2026 Suspension from 1 October 2026

Open the full view – chart and every step →

Project milestones

Elandsfontein trial production ramp-up

Phosrock production halted; restructuring begun

Led to AIM suspension over late accounts – Suspension from 1 October 2026

Elandsfontein has been in trial production since November 2025, with a March 2026 record month, then output fell in the June quarter on ore variability and contractor problems. On 7 September 2026 Kropz began an urgent restructuring: no further Phosrock production is planned, stock will be sold, and the focus moves to Nanophos. Phosrock may restart if the board approves once markets normalise.

Size: ZAR 200m (approximately US$ 12.3m)
Lender: UBI, indirect controlling shareholder of ARC; related party transaction
Interest: South African prime overdraft rate plus 6%, compounded monthly
Term: No fixed term; repayable on demand on no less than 15 business days' notice
Security: UBI first ranking, ARC second
Board view: Independent directors consider terms fair and reasonable; Gerrit Duminy did not take part

Next: MPRDA notices to Minister; Nanophos sales build-up